{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T17:56:33Z","timestamp":1778176593951,"version":"3.51.4"},"reference-count":55,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2017,3,29]],"date-time":"2017-03-29T00:00:00Z","timestamp":1490745600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0174769","type":"journal-article","created":{"date-parts":[[2017,3,29]],"date-time":"2017-03-29T18:07:45Z","timestamp":1490810865000},"page":"e0174769","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":36,"title":["Inflammation scores predict the survival of patients with hepatocellular carcinoma who were treated with transarterial chemoembolization and recombinant human type-5 adenovirus H101"],"prefix":"10.1371","volume":"12","author":[{"given":"Chao-Bin","family":"He","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8646-7060","authenticated-orcid":false,"given":"Xiao-Jun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,3,29]]},"reference":[{"issue":"2","key":"ref1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3322\/caac.21262","article-title":"Global cancer statistics, 2012","volume":"65","author":"LA Torre","year":"2015","journal-title":"CA Cancer J Clin"},{"issue":"9399","key":"ref2","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0140-6736(03)14964-1","article-title":"Hepatocellular carcinoma","volume":"362","author":"JM Llovet","year":"2003","journal-title":"The Lancet"},{"issue":"Suppl 1","key":"ref3","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.jhep.2008.01.022","article-title":"Novel advancements in the management of hepatocellular carcinoma in 2008","volume":"48","author":"JM Llovet","year":"2008","journal-title":"J Hepatol"},{"issue":"2","key":"ref4","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1053\/jhep.2003.50047","article-title":"Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival","volume":"37","author":"JM Llovet","year":"2003","journal-title":"Hepatology"},{"issue":"3","key":"ref5","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"Management of hepatocellular carcinoma: an update","volume":"53","author":"J Bruix","year":"2011","journal-title":"Hepatology"},{"issue":"5","key":"ref6","doi-asserted-by":"crossref","first-page":"S179","DOI":"10.1053\/j.gastro.2004.09.032","article-title":"Chemoembolization for hepatocellular carcinoma","volume":"127","author":"J Bruix","year":"2004","journal-title":"Gastroenterology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2147\/HMER.S31440","article-title":"Transarterial chemoembolization using iodized oil for unresectable hepatocellular carcinoma: perspective from multistep hepatocarcinogenesis","volume":"6","author":"K Yoshimitsu","year":"2014","journal-title":"Hepat Med"},{"issue":"3","key":"ref8","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.jhep.2008.12.011","article-title":"Angiogenesis in liver disease","volume":"50","author":"M Fernandez","year":"2009","journal-title":"J Hepatol"},{"issue":"4786","key":"ref9","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1126\/science.3541204","article-title":"The molecular genetics of cancer","volume":"235","author":"JM Bishop","year":"1987","journal-title":"Science"},{"issue":"9","key":"ref10","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/oxfordjournals.annonc.a058319","article-title":"Tumour suppressor genes","volume":"3","author":"JK Cowell","year":"1992","journal-title":"Ann Oncol"},{"issue":"5","key":"ref11","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/bjc.1998.126","article-title":"p53 mutation is a poor prognostic indicator for survival in patients with hepatocellular carcinoma undergoing surgical tumour ablation","volume":"77","author":"K Honda","year":"1998","journal-title":"Br J Cancer"},{"issue":"7","key":"ref12","doi-asserted-by":"crossref","first-page":"e68574","DOI":"10.1371\/journal.pone.0068574","article-title":"Recombinant human adenovirus-p53 injection induced apoptosis in hepatocellular carcinoma cell lines mediated by p53-Fbxw7 pathway, which controls c-Myc and cyclin E","volume":"8","author":"K Tu","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"ref13","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/CAD.0b013e32832a2df9","article-title":"Multiple hepatic arterial injections of recombinant adenovirus p53 and 5-fluorouracil after transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: a pilot phase II trial","volume":"20","author":"G Tian","year":"2009","journal-title":"Anticancer Drugs"},{"issue":"16","key":"ref14","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.3748\/wjg.v17.i16.2143","article-title":"p53 gene therapy in combination with transcatheter arterial chemoembolization for HCC: one-year follow-up","volume":"17","author":"YS Guan","year":"2011","journal-title":"World J Gastroenterol"},{"issue":"4","key":"ref15","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00432-009-0701-6","article-title":"Clinical study of recombinant adenovirus-p53 combined with fractionated stereotactic radiotherapy for hepatocellular carcinoma","volume":"136","author":"ZX Yang","year":"2010","journal-title":"J Cancer Res Clin Oncol"},{"issue":"2","key":"ref16","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2174\/156800907780058826","article-title":"Oncolytic virus therapy\u2014foreword","volume":"7","author":"H Kasuya","year":"2007","journal-title":"Curr Cancer Drug Targets"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/mt.2008.236","article-title":"Enhanced therapeutic efficacy by simultaneously targeting two genetic defects in tumors","volume":"17","author":"H Zhang","year":"2009","journal-title":"Mol Ther"},{"issue":"13","key":"ref18","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1056\/NEJMra0802714","article-title":"Lung cancer","volume":"359","author":"RS Herbst","year":"2008","journal-title":"N Engl J Med"},{"issue":"5","key":"ref19","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1167\/iovs.09-3516","article-title":"Inhibition of retinoblastoma in vitro and in vivo with conditionally replicating oncolytic adenovirus H101","volume":"51","author":"X Song","year":"2010","journal-title":"Investigative ophthalmology & visual science"},{"issue":"2","key":"ref20","doi-asserted-by":"crossref","first-page":"555","DOI":"10.3892\/ijo.2015.3045","article-title":"The antitumor effects of oncolytic adenovirus H101 against lung cancer","volume":"47","author":"J Lei","year":"2015","journal-title":"International journal of oncology"},{"issue":"21","key":"ref21","first-page":"6070","article-title":"Hepatic arterial infusion of a replication-selective oncolytic adenovirus (dl1520): phase II viral, immunologic, and clinical endpoints","volume":"62","author":"T Reid","year":"2002","journal-title":"Cancer Res"},{"issue":"11","key":"ref22","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1111\/jgh.13009","article-title":"p53 gene therapy-based transarterial chemoembolization for unresectable hepatocellular carcinoma: A prospective cohort study","volume":"30","author":"A Shen","year":"2015","journal-title":"J Gastroenterol Hepatol"},{"issue":"3","key":"ref23","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1245\/s10434-015-4929-x","article-title":"Surgical Resection is Better than Transarterial Chemoembolization for Patients with Hepatocellular Carcinoma Beyond the Milan Criteria: A Prognostic Nomogram Study","volume":"23","author":"CY Hsu","year":"2016","journal-title":"Annals of surgical oncology"},{"issue":"3","key":"ref24","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/hep.510280322","article-title":"A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigators","volume":"28","year":"1998","journal-title":"Hepatology"},{"issue":"6917","key":"ref25","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"LM Coussens","year":"2002","journal-title":"Nature"},{"issue":"3","key":"ref26","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/(SICI)1097-0142(20000201)88:3<577::AID-CNCR13>3.0.CO;2-V","article-title":"Prognostic value of intratumoral natural killer cells in gastric carcinoma","volume":"88","author":"S Ishigami","year":"2000","journal-title":"Cancer"},{"issue":"21","key":"ref27","doi-asserted-by":"crossref","first-page":"18563","DOI":"10.1074\/jbc.M010787200","article-title":"Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice","volume":"276","author":"CH Liu","year":"2001","journal-title":"The Journal of biological chemistry"},{"issue":"3","key":"ref28","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S0002-9440(10)64255-1","article-title":"Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis","volume":"161","author":"SF Schoppmann","year":"2002","journal-title":"The American journal of pathology"},{"issue":"6","key":"ref29","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S1535-6108(03)00310-6","article-title":"Targeting cyclooxygenase-2 in human neoplasia: rationale and promise","volume":"4","author":"AJ Dannenberg","year":"2003","journal-title":"Cancer cell"},{"issue":"7203","key":"ref30","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"A Mantovani","year":"2008","journal-title":"Nature"},{"issue":"4","key":"ref31","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nrc1586","article-title":"Immunosuppressive networks in the tumour environment and their therapeutic relevance","volume":"5","author":"W Zou","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"ref32","article-title":"Prognostic value of combined preoperative fibrinogen and neutrophil-lymphocyte ratio in patients with hepatocellular carcinoma after liver transplantation","author":"SJ Fu","year":"2016","journal-title":"Oncotarget"},{"key":"ref33","article-title":"Clinicopathological and prognostic significance of platelet-to-lymphocyte ratio in patients with hepatocellular carcinoma","author":"W Song","year":"2016","journal-title":"Oncotarget"},{"issue":"7","key":"ref34","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/hepr.12597","article-title":"Prediction of long-term survival by using the Glasgow Prognostic Score in patients with hepatocellular carcinoma after liver transplantation","volume":"46","author":"T Abe","year":"2016","journal-title":"Hepatology research: the official journal of the Japan Society of Hepatology"},{"key":"ref35","article-title":"Prognostic nutritional index predicts short-term outcomes after liver resection for hepatocellular carcinoma within the Milan criteria","author":"M Ke","year":"2016","journal-title":"Oncotarget"},{"issue":"4","key":"ref36","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3747\/co.v17i4.567","article-title":"The predictive value of pre-treatment inflammatory markers in advanced non-small-cell lung cancer","volume":"17","author":"G Kasymjanova","year":"2010","journal-title":"Curr Oncol"},{"issue":"2","key":"ref37","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1245\/s10434-010-1321-8","article-title":"Transarterial chemoembolization for unresectable hepatocellular carcinoma with portal vein tumor thrombosis: a prospective comparative study","volume":"18","author":"J Luo","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1186\/s12885-015-1715-x","article-title":"Transarterial injection of recombinant human type-5 adenovirus H101 in combination with transarterial chemoembolization (TACE) improves overall and progressive-free survival in unresectable hepatocellular carcinoma (HCC)","volume":"15","author":"XJ Lin","year":"2015","journal-title":"BMC Cancer"},{"issue":"3","key":"ref39","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0168-8278(01)00130-1","article-title":"Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver","volume":"35","author":"J Bruix","year":"2001","journal-title":"J Hepatol"},{"issue":"8","key":"ref40","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1097\/MCG.0b013e3182a8a254","article-title":"Vascular invasion in hepatocellular carcinoma: prevalence, determinants and prognostic impact","volume":"48","author":"YH Lee","year":"2014","journal-title":"J Clin Gastroenterol"},{"issue":"5","key":"ref41","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1053\/jhep.2002.33156","article-title":"Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma","volume":"35","author":"CM Lo","year":"2002","journal-title":"Hepatology"},{"issue":"9319","key":"ref42","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/S0140-6736(02)08649-X","article-title":"Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial","volume":"359","author":"JM Llovet","year":"2002","journal-title":"Lancet"},{"issue":"2","key":"ref43","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s12072-010-9165-7","article-title":"Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma","volume":"4","author":"M Omata","year":"2010","journal-title":"Hepatol Int"},{"issue":"12","key":"ref44","doi-asserted-by":"crossref","first-page":"9470","DOI":"10.1128\/JVI.72.12.9470-9478.1998","article-title":"Replication of ONYX-015, a potential anticancer adenovirus, is independent of p53 status in tumor cells","volume":"72","author":"T Rothmann","year":"1998","journal-title":"J Virol"},{"issue":"6","key":"ref45","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nm0697-639","article-title":"ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents","volume":"3","author":"C Heise","year":"1997","journal-title":"Nat Med"},{"issue":"4","key":"ref46","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1089\/10430349950018652","article-title":"Targeting the replication of adenoviral gene therapy vectors to lung cancer cells: the importance of the adenoviral E1b-55kD gene","volume":"10","author":"JG Hay","year":"1999","journal-title":"Hum Gene Ther"},{"issue":"9255","key":"ref47","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","article-title":"Inflammation and cancer: back to Virchow?","volume":"357","author":"F Balkwill","year":"2001","journal-title":"Lancet"},{"issue":"1","key":"ref48","first-page":"184","article-title":"Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism","volume":"60","author":"M Jaiswal","year":"2000","journal-title":"Cancer Res"},{"issue":"1","key":"ref49","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nrc1782","article-title":"Paradoxical roles of the immune system during cancer development","volume":"6","author":"KE de Visser","year":"2006","journal-title":"Nat Rev Cancer"},{"issue":"18","key":"ref50","doi-asserted-by":"crossref","first-page":"5582","DOI":"10.3748\/wjg.v21.i18.5582","article-title":"Inflammation scores predict survival for hepatitis B virus-related hepatocellular carcinoma patients after transarterial chemoembolization","volume":"21","author":"DS Zhou","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"1","key":"ref51","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jss.2015.05.003","article-title":"Postoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio predicts the outcomes of hepatocellular carcinoma","volume":"198","author":"C Li","year":"2015","journal-title":"J Surg Res"},{"issue":"12","key":"ref52","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1002\/cncr.25044","article-title":"Selecting an optimal staging system for hepatocellular carcinoma: comparison of 5 currently used prognostic models","volume":"116","author":"CY Hsu","year":"2010","journal-title":"Cancer"},{"key":"ref53","article-title":"Incorporation of alpha-fetoprotein(AFP) into subclassification of BCLC C stage hepatocellular carcinoma according to a 5-year survival analysis based on the SEER database","author":"N Zhang","year":"2016","journal-title":"Oncotarget"},{"issue":"17","key":"ref54","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1200\/JCO.2009.25.9895","article-title":"Advanced hepatocellular carcinoma: which staging systems best predict prognosis?","volume":"28","author":"FD Huitzil-Melendez","year":"2010","journal-title":"J Clin Oncol"},{"issue":"4","key":"ref55","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jhep.2005.12.015","article-title":"Prospective validation of the Barcelona Clinic Liver Cancer staging system","volume":"44","author":"U Cillo","year":"2006","journal-title":"J Hepatol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0174769","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,4]],"date-time":"2020-10-04T16:14:32Z","timestamp":1601828072000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0174769"}},"subtitle":[],"editor":[{"given":"Sheng-Nan","family":"Lu","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,3,29]]},"references-count":55,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,3,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0174769","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,29]]}}}